Search Results
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Mette Bøgehave in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Odense, Denmark
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Jørgen Brodersen Gram in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Else-Marie Bladbjerg in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Johannes Jakobsen Sidelmann in
Google Scholar
PubMed
.5) 19.4 (14.3; 26.8) <0.01 Sex hormone-binding globulin (nmol/L) a 32.2 (24.5; 44.5) 31.5 (20.7; 51.2) 0.48 41.9 (24.5; 51.7) 36.9 (24.6; 45.9) <0.01 Bioavailable testosterone (nmol/L) a 3.5 (2.1; 4.4) 3.0 (1.9; 4.1) 0
Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Andre Madsen in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
evaluated in our own laboratory. We performed internal validations and method comparisons and were therefore able to compare measurements, although the methods for measuring sex hormone-binding globulin (SHBG) and anti-Müllerian hormone (AMH) changed during
Search for other papers by Xiying Zeng in
Google Scholar
PubMed
Search for other papers by Yinxiang Huang in
Google Scholar
PubMed
Search for other papers by Mulin Zhang in
Google Scholar
PubMed
Search for other papers by Yun Chen in
Google Scholar
PubMed
Search for other papers by Jiawen Ye in
Google Scholar
PubMed
Search for other papers by Yan Han in
Google Scholar
PubMed
Search for other papers by Danyan Ma in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Xiaohong Yan in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, The First Affiliated Hospital, Xiamen University, Xiamen, China
Fujian Province Key Laboratory of Diabetes Translational Medicine, Xiamen, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
hypothesis requires further biological research. In addition, hyperinsulinemia resulting from IR stimulates ovarian steroidogenesis and inhibits sex hormone-binding globulin production in the liver, thereby increasing the availability of free androgens. The
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
release of androstenedione and testosterone ( 78 ). Indeed, insulin acts as a co-gonadotropin to increase luteinizing hormone (LH), therefore, stimulating androgens production. A concomitant decrease in sex hormone binding globulin (SHBG) mediated both by
Search for other papers by Feifei Cheng in
Google Scholar
PubMed
Search for other papers by Noel Yat Hey Ng in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Claudia Ha Ting Tam in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Yuying Zhang in
Google Scholar
PubMed
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Cadmon King Poo Lim in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Guozhi Jiang in
Google Scholar
PubMed
Search for other papers by Alex Chi Wai Ng in
Google Scholar
PubMed
Search for other papers by Tiffany Tse Ling Yau in
Google Scholar
PubMed
Search for other papers by Lai Ping Cheung in
Google Scholar
PubMed
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, Hong Kong
Department of Pharmacy and Pharmacology, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Aimin Xu in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Chinese University of Hong Kong-Shanghai Jiao Tong University Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, Hong Kong
Search for other papers by Juliana C N Chan in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Chinese University of Hong Kong-Shanghai Jiao Tong University Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, Hong Kong
Search for other papers by Ronald C W Ma in
Google Scholar
PubMed
hormone-binding globulin (SHBG) were associated with the development of T2DM in PCOS patients ( 5 , 6 ). In a long-term follow-up study from Hong Kong, the incidence rate of diabetes in PCOS was 22.12 per 1000 person-years, which was more than doubled
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alberto Sánchez-Guijo in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Punnonen K Mustajoki P Kaukua J Rissanen A. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome . Diabetes, Obesity and Metabolism 2004 6 208 – 215
Search for other papers by Dirk-Jan van Beek in
Google Scholar
PubMed
Search for other papers by Rachel S van Leeuwaarde in
Google Scholar
PubMed
Search for other papers by Carolina R C Pieterman in
Google Scholar
PubMed
Search for other papers by Menno R Vriens in
Google Scholar
PubMed
Parelsnoer Institute, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Search for other papers by the DutchMEN Study Group in
Google Scholar
PubMed
/CT, positron emission tomography/computed tomography; pHPT, primary hyperparathyroidism; PIT, pituitary; PPI, proton-pump inhibitor; PTH, parathyroid hormone; R-status, resection margin status; SHBG, sex hormone-binding globulin; SU, sulphonylurea; TSH, thyroid
Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Search for other papers by Jennifer Lo in
Google Scholar
PubMed
Search for other papers by Natasha Ascui in
Google Scholar
PubMed
Search for other papers by Matthew J Watt in
Google Scholar
PubMed
further compounded by the suppressed synthesis of sex-hormone binding globulin (SHBG) (66) , a carrier protein that specifically binds circulating testosterone and reduces its bioavailability to peripheral tissues. Thus, both total and bioavailable
Search for other papers by Sakina Kherra in
Google Scholar
PubMed
Search for other papers by Wendy Forsyth Paterson in
Google Scholar
PubMed
Search for other papers by Filiz Mine Cizmecioglu in
Google Scholar
PubMed
Search for other papers by Jeremy Huw Jones in
Google Scholar
PubMed
Search for other papers by Mariam Kourime in
Google Scholar
PubMed
Search for other papers by Heba Hassan Elsedfy in
Google Scholar
PubMed
Search for other papers by Sameh Tawfik in
Google Scholar
PubMed
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Search for other papers by Mohamad Guftar Shaikh in
Google Scholar
PubMed
Search for other papers by Malcolm David Cairns Donaldson in
Google Scholar
PubMed
females and sex hormone-binding globulin (SHBG) and anti-Mullerian hormone (AMH) in both sexes were not measured sufficiently regularly to be analysed in this study. Assay detection limits for LH and FSH were <0.5 U/L until 2010, <0.1 from 2010 to 2014
Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
Search for other papers by Angelica Lindén Hirschberg in
Google Scholar
PubMed
of sex hormone-binding globulin (SHBG), thereby elevating levels of free and bioavailable testosterone. Moreover, insulin resistance may lead to metabolic changes including abdominal obesity. This condition is usually managed by treating the